Theresa Williamson1,2, Marc D Ryser3, Peter A Ubel4,5, Jihad Abdelgadir1,2, Charis A Spears1,2, Beiyu Liu2, Jordan Komisarow1,2, Monica E Lemmon2,6, Aladine Elsamadicy1, Shivanand P Lad1,2. 1. Duke University Medical Center, Department of Neurosurgery, Durham, North Carolina. 2. Duke University School of Medicine, Duke University, Durham, North Carolina. 3. Duke University Medical Center, Department of Population Health Sciences, Durham, North Carolina. 4. Duke-Margolis Center for Health Policy, Durham, North Carolina. 5. The Fuqua School of Business, Duke University, Durham, North Carolina. 6. Duke University Medical Center, Department of Pediatrics, Durham, North Carolina.
Abstract
Importance: There are limited data on which factors affect the critical and complex decision to withdraw life-supporting treatment (LST) in patients with severe traumatic brain injury (sTBI). Objective: To determine demographic and clinical factors associated with the decision to withdraw LST in patients with sTBI. Design, Setting, and Participants: This retrospective analysis of inpatient data from more than 825 trauma centers across the US in the American College of Surgeons Trauma Quality Improvement Program database from January 2013 to December 2015 included adult patients with sTBI and documentation of a decision regarding withdrawal of LST (WLST). Data analysis was conducted in September 2019. Main Outcomes and Measures: Factors associated with WLST in sTBI. Results: A total of 37931 patients (9817 women [25.9%]) were included in the multivariable analysis; 7864 (20.7%) had WLST. Black patients (4806 [13.2%]; odds ratio [OR], 0.66; 95% CI, 0.59-0.72; P < .001) and patients of other race (4798 [13.2%]; OR, 0.83; 95% CI, 0.76-0.91; P < .001) were less likely than white patients (26 864 [73.7%]) to have WLST. Patients from hospitals in the Midwest (OR, 1.12; 95% CI, 1.04-1.20; P = .002) or Northeast (OR, 1.23; 95% CI, 1.13-1.34; P < .001) were more likely to have WLST than patients from hospitals in the South. Patients with Medicare (OR, 1.55; 95% CI, 1.43-1.69; P < .001) and self-pay patients (OR, 1.36; 95% CI, 1.25-1.47; P < .001) were more likely to have WLST than patients with private insurance. Older patients and those with lower Glasgow Coma Scale scores, higher Injury Severity Scores, or craniotomy were generally more likely to have WLST. Withdrawal of LST was more likely for patients with functionally dependent health status (OR, 1.30; 95% CI, 1.08-1.58; P = .01), hematoma (OR, 1.19; 95% CI, 1.12-1.27; P < .001), dementia (OR, 1.29; 95% CI, 1.08-1.53; P = .004), and disseminated cancer (OR, 2.82; 95% CI, 2.07-3.82; P < .001) than for patients without these conditions. Conclusions and Relevance: Withdrawal of LST is common in sTBI and socioeconomic factors are associated with the decision to withdraw LST. These results highlight the many factors that contribute to decision-making in sTBI and demonstrate that in a complex and variable disease process, variation based on race, payment, and region presents as a potential challenge.
Importance: There are limited data on which factors affect the critical and complex decision to withdraw life-supporting treatment (LST) in patients with severe traumatic brain injury (sTBI). Objective: To determine demographic and clinical factors associated with the decision to withdraw LST in patients with sTBI. Design, Setting, and Participants: This retrospective analysis of inpatient data from more than 825 trauma centers across the US in the American College of Surgeons Trauma Quality Improvement Program database from January 2013 to December 2015 included adult patients with sTBI and documentation of a decision regarding withdrawal of LST (WLST). Data analysis was conducted in September 2019. Main Outcomes and Measures: Factors associated with WLST in sTBI. Results: A total of 37931 patients (9817 women [25.9%]) were included in the multivariable analysis; 7864 (20.7%) had WLST. Black patients (4806 [13.2%]; odds ratio [OR], 0.66; 95% CI, 0.59-0.72; P < .001) and patients of other race (4798 [13.2%]; OR, 0.83; 95% CI, 0.76-0.91; P < .001) were less likely than white patients (26 864 [73.7%]) to have WLST. Patients from hospitals in the Midwest (OR, 1.12; 95% CI, 1.04-1.20; P = .002) or Northeast (OR, 1.23; 95% CI, 1.13-1.34; P < .001) were more likely to have WLST than patients from hospitals in the South. Patients with Medicare (OR, 1.55; 95% CI, 1.43-1.69; P < .001) and self-pay patients (OR, 1.36; 95% CI, 1.25-1.47; P < .001) were more likely to have WLST than patients with private insurance. Older patients and those with lower Glasgow Coma Scale scores, higher Injury Severity Scores, or craniotomy were generally more likely to have WLST. Withdrawal of LST was more likely for patients with functionally dependent health status (OR, 1.30; 95% CI, 1.08-1.58; P = .01), hematoma (OR, 1.19; 95% CI, 1.12-1.27; P < .001), dementia (OR, 1.29; 95% CI, 1.08-1.53; P = .004), and disseminated cancer (OR, 2.82; 95% CI, 2.07-3.82; P < .001) than for patients without these conditions. Conclusions and Relevance: Withdrawal of LST is common in sTBI and socioeconomic factors are associated with the decision to withdraw LST. These results highlight the many factors that contribute to decision-making in sTBI and demonstrate that in a complex and variable disease process, variation based on race, payment, and region presents as a potential challenge.
Authors: Uma V Mahajan; Hammad A Khan; Xiaofei Zhou; Shaarada Srivatsa; Christina H Wright; Adam H Bates; Martha Sajatovic; Nicholas C Bambakidis Journal: Neurocrit Care Date: 2022-09-16 Impact factor: 3.532
Authors: Belinda S DeMario; Samuel P Stanley; Evelyn I Truong; Husayn A Ladhani; Laura R Brown; Vanessa P Ho; Michael L Kelly Journal: Neurosurgery Date: 2022-04-28 Impact factor: 5.315
Authors: Connie Ge; Adeline L Goss; Sybil Crawford; Kelsey Goostrey; Praewpannarai Buddadhumaruk; Anne-Marie Shields; Catherine L Hough; Bernard Lo; Shannon S Carson; Jay Steingrub; Douglas B White; Susanne Muehlschlegel Journal: Crit Care Explor Date: 2022-02-21
Authors: Raimund Helbok; Verena Rass; Ettore Beghi; Yelena G Bodien; Giuseppe Citerio; Joseph T Giacino; Daniel Kondziella; Stephan A Mayer; David Menon; Tarek Sharshar; Robert D Stevens; Hanno Ulmer; Chethan P Venkatasubba Rao; Paul Vespa; Molly McNett; Jennifer Frontera Journal: Neurocrit Care Date: 2022-02-09 Impact factor: 3.532
Authors: Jan Claassen; Yama Akbari; Sheila Alexander; Mary Kay Bader; Kathleen Bell; Thomas P Bleck; Melanie Boly; Jeremy Brown; Sherry H-Y Chou; Michael N Diringer; Brian L Edlow; Brandon Foreman; Joseph T Giacino; Olivia Gosseries; Theresa Green; David M Greer; Daniel F Hanley; Jed A Hartings; Raimund Helbok; J Claude Hemphill; H E Hinson; Karen Hirsch; Theresa Human; Michael L James; Nerissa Ko; Daniel Kondziella; Sarah Livesay; Lori K Madden; Shraddha Mainali; Stephan A Mayer; Victoria McCredie; Molly M McNett; Geert Meyfroidt; Martin M Monti; Susanne Muehlschlegel; Santosh Murthy; Paul Nyquist; DaiWai M Olson; J Javier Provencio; Eric Rosenthal; Gisele Sampaio Silva; Simone Sarasso; Nicholas D Schiff; Tarek Sharshar; Lori Shutter; Robert D Stevens; Paul Vespa; Walter Videtta; Amy Wagner; Wendy Ziai; John Whyte; Elizabeth Zink; Jose I Suarez Journal: Neurocrit Care Date: 2021-07-08 Impact factor: 3.210
Authors: Alexis Steinberg; Benjamin S Abella; Emily J Gilmore; David Y Hwang; Niki Kennedy; Winnie Lau; Isabelle Mullen; Nidhi Ravishankar; Charlotte F Tisch; Adam Waddell; David J Wallace; Qiang Zhang; Jonathan Elmer Journal: Crit Care Explor Date: 2021-07-13